Lutterbach, Bart
Merck & Co., Inc., Rahway, NJ, USA (United States)
3 papers on CoChat
Most cited papers
- Verified
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
Morris, E. J., Jha, S., Restaino, C. R., Dayananth, P., Zhu, H., Cooper, A., Carr, D., Deng, Y., Jin, W., Black, S., et al. (2013) · Cancer Discovery
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 676
- Verified
Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein
Fenrick, R., Amann, J. M., Lutterbach, B., Wang, L., Westendorf, J. J., Downing, J. R., & Hiebert, S. W. (1999) · Molecular and Cellular Biology
Acute Lymphoblastic Leukemia researchGenomics and Chromatin Dynamics
Cited by 162
- Verified
The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain
Durst, K. L., Lutterbach, B., Kummalue, T., Friedman, A. D., & Hiebert, S. W. (2003) · Molecular and Cellular Biology
Acute Myeloid Leukemia ResearchGenomics and Chromatin Dynamics
Cited by 161
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free